{"id":"W2755955412","doi":"10.1053/j.seminoncol.2017.08.004","title":"Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients","year":2017,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Ovarian cancer; Olaparib; Medicine; Germline; Genetic testing; Germline mutation; PARP inhibitor; Oncology; Cancer; Somatic cell; Breast cancer; Internal medicine; BRCA mutation; Mutation; Cancer research; Gynecology; Polymerase; Poly ADP ribose polymerase; Genetics; DNA; Biology; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006491616,0.0004361832,0.001076061,0.0002459283,0.0000870996,0.00002385425,0.0007303774,0.0005393348,0.00003749001],"category_scores_gemma":[0.0008864959,0.000431747,0.0001340037,0.0002235235,0.0001445795,0.000004480083,0.0003281496,0.0004875534,0.00002673624],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002163214,"about_ca_system_score_gemma":0.002510556,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001791019,"about_ca_topic_score_gemma":0.0009032098,"domain_scores_codex":[0.9971369,0.0003250984,0.0009439172,0.000891587,0.0001751959,0.0005273353],"domain_scores_gemma":[0.9980178,0.0001416673,0.0008713276,0.0007856556,0.0001128372,0.00007075026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003055099,0.0002522357,0.002758849,0.001041275,0.00005332841,0.00007053871,0.00005292438,0.00007870041,0.00002941328,0.000007897971,0.005567078,0.9900572],"study_design_scores_gemma":[0.0007699804,0.0004946784,0.0007508644,0.007333492,0.0000584009,0.00001294566,0.00001417922,0.000005544806,0.0000731535,0.00002883951,0.9900442,0.0004137327],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001469587,0.9900349,0.000004932134,0.00007519507,0.001406842,0.001003563,0.0001803556,0.000007541723,0.005817108],"genre_scores_gemma":[0.0006239607,0.9946919,0.001481865,0.0002617197,0.000382079,0.001390744,0.0002919275,0.00008250845,0.0007932937],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9896435,"threshold_uncertainty_score":0.9998134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07812918806627712,"score_gpt":0.4238238305409072,"score_spread":0.3456946424746301,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}